ATXS - Astria Therapeutics, Inc.

QQQ $ 602.34 $ -5.20 (-0.85 %)

DIA $ 466.18 $ -5.48 (-1.16 %)

SPY $ 664.83 $ -6.26 (-0.93 %)

TLT $ 89.11 $ 0.22 (0.25 %)

GLD $ 370.86 $ -4.31 (-1.15 %)

Previous Close

$ 12.57

Open

$ 12.47

Bid

$ 12.55 x 1,642

Ask

$ 12.56 x 1,400

Day's Range

$ 12.47 - $ 12.61

52 Week Range

$ 3.56 - $ 12.72

Volume

1,040,741

Average Volume

Market Cap

729.13M

Beta (5Y Monthly)

$ 1.06

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-12-2025	09-30-2025	10-Q
2	08-12-2025	06-30-2025	10-Q
3	05-13-2025	03-31-2025	10-Q
4	03-11-2025	12-31-2024	10-K
5	11-13-2024	09-30-2024	10-Q
6	08-12-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	03-04-2024	12-31-2023	10-K
9	11-13-2023	09-30-2023	10-Q
10	08-07-2023	06-30-2023	10-Q
11	05-11-2023	03-31-2023	10-Q
12	03-22-2023	12-31-2022	10-K
13	11-10-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-12-2022	03-31-2022	10-Q
16	03-10-2022	12-31-2021	10-K
17	11-10-2021	09-30-2021	10-Q
18	08-09-2021	06-30-2021	10-Q
19	05-13-2021	03-31-2021	10-Q
20	03-11-2021	12-31-2020	10-K
21	11-12-2020	09-30-2020	10-Q
22	08-10-2020	06-30-2020	10-Q
23	05-12-2020	03-31-2020	10-Q
24	03-10-2020	12-31-2019	10-K
25	11-07-2019	09-30-2019	10-Q
26	08-08-2019	06-30-2019	10-Q
27	05-14-2019	03-31-2019	10-Q
28	03-14-2019	12-31-2018	10-K
29	11-13-2018	09-30-2018	10-Q
30	08-09-2018	06-30-2018	10-Q
31	05-10-2018	03-31-2018	10-Q
32	03-15-2018	12-31-2017	10-K
33	11-09-2017	09-30-2017	10-Q
34	08-10-2017	06-30-2017	10-Q
35	05-11-2017	03-31-2017	10-Q
36	03-16-2017	12-31-2016	10-K
37	11-10-2016	09-30-2016	10-Q
38	08-11-2016	06-30-2016	10-Q
39	05-12-2016	03-31-2016	10-Q
40	03-15-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Downgrades Astria Therap...
11/12/2025 19:06:17

Cantor Fitzgerald analyst Steven Seedhouse downgrades Astria Therapeutics (NASDAQ:ATXS) from Overweight to Neutral.

Astria Therapeutics Q3 EPS $(0.55) Misses ...
11/12/2025 13:06:08

Astria Therapeutics (NASDAQ:ATXS) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of...

Astria Therapeutics ALPHA-STAR Phase 1b/2 ...
11/06/2025 13:14:41

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic...

Astria Therapeutics To Present Final Resul...
10/31/2025 12:06:26

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic...

this-verisk-analytics-analyst-turns-bearish-here-are-top-5-downgrades-for-thursday

This Verisk Analytics Analyst Turns Bearis...
10/16/2025 13:01:42

HC Wainwright & Co. Downgrades Astria Ther...
10/16/2025 10:47:44

HC Wainwright & Co. analyst Joseph Pantginis downgrades Astria Therapeutics (NASDAQ:ATXS) from Buy to Neutral.

Wedbush Downgrades Astria Therapeutics to ...
10/15/2025 15:15:04

Wedbush analyst Laura Chico downgrades Astria Therapeutics (NASDAQ:ATXS) from Outperform to Neutral and lowers the price tar...

JMP Securities Downgrades Astria Therapeut...
10/15/2025 11:18:47

JMP Securities analyst Jonathan Wolleben downgrades Astria Therapeutics (NASDAQ:ATXS) from Market Outperform to Market Perform.

Jefferies Downgrades Astria Therapeutics t...
10/14/2025 18:18:58

Jefferies analyst Eun Yang downgrades Astria Therapeutics (NASDAQ:ATXS) from Buy to Hold and lowers the price target from $3...

dow-jumps-over-300-points-citigroup-posts-upbeat-earnings

Dow Jumps Over 300 Points; Citigroup Posts...
10/14/2025 17:09:06

12 Health Care Stocks Moving In Tuesday's ...
10/14/2025 17:06:11

biocryst-says-astria-therapeutics-700-million-deal-gives-perfect-second-product-candidate

BioCryst Says Astria Therapeutics $700 Mil...
10/14/2025 16:20:52

BioCryst will acquire Astria Therapeutics for $700 million to expand its HAE portfolio with navenibart, aiming for double-digit...

dominos-pizza-posts-upbeat-results-joins-astria-therapeutics-albertsons-companies-polaris-and-other-big-stocks-moving-higher-on-tuesday

Domino's Pizza Posts Upbeat Results, Joins...
10/14/2025 14:15:51

12 Health Care Stocks Moving In Tuesday's ...
10/14/2025 12:09:03

Trading Halt: Halt status updated at 7:15:...
10/14/2025 11:15:04

BioCryst to Acquire Astria Therapeutics fo...
10/14/2025 11:02:17

Trading Halt: Halted at 6:55:00 a.m. ET - ...
10/14/2025 10:55:04

Astria Therapeutics Initiates Phase 3 ORBI...
10/08/2025 14:09:30

Astria Therapeutics To Present New Data On...
10/03/2025 12:04:05

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic...

Astria Therapeutics Begins Opening Clinica...
10/02/2025 12:06:52

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic...